HYEEUN JEONG: Open Payments
NPI 1396231999 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,910 in 119 payments from 20 companies in 2025. Trend: 2023 $479 · 2024 $1,879 · 2025 $3,910
Food & beverage: $3,862Education: $48
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 16 | $567 |
| Arcutis Biotherapeutics, Inc. | 9 | $454 |
| LEO Pharma Inc. | 6 | $387 |
| Novartis Pharmaceuticals Corporation | 12 | $330 |
| GENZYME CORPORATION | 5 | $291 |
| Janssen Biotech, Inc. | 6 | $268 |
| Botanix SB Inc | 6 | $229 |
| Lilly USA, LLC | 7 | $214 |
| Galderma Laboratories, L.P. | 9 | $209 |
| ABBVIE INC. | 7 | $181 |
Products named: OPZELURA, Zoryve, DUPIXENT, COSENTYX, TREMFYA, SOFDRA, ANZUPGO, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
